For the Inventor, By the Inventor

Enter assignee name

Bedford, MA, United States of America

Nitromed, Inc.

USPTO Granted Patents = 90

% Expired Patents = 38.9

Forward Citations = 1,562

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

David S Garvey (75 out of 101 patents)

L Gordon Letts (35 out of 44 patents)

Inigo Saenz De Tejada (31 out of 32 patents)

4. Stewart K Richardson (18 out of 26 patents)

5. Sang William Tam (18 out of 19 patents)

6. Joseph David Schroeder (17 out of 33 patents)

7. H Burt Renfroe (16 out of 17 patents)

8. Xinqin Fang (12 out of 18 patents)

9. Subhash P Khanapure (11 out of 17 patents)

10. Tiansheng Wang (10 out of 68 patents)

11. Richard A Earl (10 out of 17 patents)

12. Chia-En Lin (10 out of 16 patents)

13. Ricky D Gaston (8 out of 14 patents)

14. Ramani R Ranatunge (8 out of 14 patents)

15. Manuel Worcel (8 out of 9 patents)

Core Competencies:

Nitric Oxide

Vascular Diseases

Cyclooxygenase-2

Nitrosated Compounds

Prostaglandins

Diuretic Compounds

Respiratory Disorders

Phosphodiesterase Inhibitors

Alpha-Adrenergic Receptor

Sexual Dysfunction

Toxicity Prevention

Hydralazine

90 patents: Sort by Forward Citations

1. 8067464 - Compositions and methods using apocynin compounds and nitric oxide donors (2011-11-29),

2. 7838023 - Furoxan compounds, compositions and methods of use (2010-11-23),

3. 7772278 - Nitrosated and nitrosylated prostaglandins, compositions and methods of use (2010-08-10),

4. 7708989 - Methods of treating vascular diseases characterized by nitric oxide insufficiency (2010-05-04),

5. 7556824 - Transdermal patch composition for treating vascular diseases characterized by nitric oxide insufficiency (2009-07-07),

6. 7537785 - Composition for treating vascular diseases characterized by nitric oxide insufficiency (2009-05-26),

7. 7449595 - Nitrosated and nitrosylated prostaglandins, compositions and methods of use (2008-11-11),

8. 7442802 - Cyclooxygenase-2 selective inhibitors, compositions and methods of use (2008-10-28),

9. 7432285 - Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use (2008-10-07),

10. 7396829 - Nitric oxide enhancing diuretic compounds, compositions and methods of use (2008-07-08),

11. 7384976 - Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use (2008-06-10),

12. 7345053 - Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use (2008-03-18),

13. 7345037 - Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders (2008-03-18),

14. 7332505 - Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use (2008-02-19),

15. 7282519 - Nitrosated and nitrosylated diuretic compounds, compositions and methods of use (2007-10-16),

Nitromed, Inc., based in Bedford, MA, specializes in the development of nitric oxide compounds aimed at addressing various vascular diseases and respiratory disorders. The company focuses on innovative therapeutic solutions that leverage the properties of nitric oxide, including its role in modulating cyclooxygenase-2 and prostaglandins. Through its research, Nitromed aims to enhance treatment options for conditions related to diuretic compounds and phosphodiesterase inhibitors, contributing to advancements in cardiovascular and pulmonary health.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

90 Patents

#7 in Bedford, MA

#226 in Massachusetts

#4,146 in US

#8,519 in the World

Bedford, MA, United States of America

Nitromed, Inc.

Forward Citations = 1,562

36 inventors:

David S Garvey (75 out of 101 patents)

L Gordon Letts (35 out of 44 patents)

Inigo Saenz De Tejada (31 out of 32 patents)

4. Stewart K Richardson (18 out of 26 patents)

5. Sang William Tam (18 out of 19 patents)

Please report any incorrect information to [email protected]

Loading…